Yellowstone Partners’s iShares Biotechnology ETF IBB Stock Holding History

Yellowstone Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$274K	Buy	2,835 +75	+3%	+$7.13K	0.1%	178
2016 Q2	$237K	Sell	2,760 -66	-2%	-$5.92K	0.1%	166
2016 Q1	$246K	Sell	2,826 -30	-1%	-$2.68K	0.11%	162
2015 Q4	$322K	Hold	2,856	–	–	0.15%	127
2015 Q3	$289K	Sell	2,856 -126	-4%	-$15.1K	0.14%	133
2015 Q2	$367K	Sell	2,982 -297	-9%	-$35.6K	0.17%	110
2015 Q1	$375K	Buy	3,279 +69	+2%	+$7.61K	0.19%	102
2014 Q4	$325K	Hold	3,210	–	–	0.18%	111
2014 Q3	$293K	Sell	3,210 -15	-0.5%	-$1.32K	0.17%	115
2014 Q2	$276K	Buy	+3,225	New	+$254K	0.16%	125

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Yellowstone Partners's IBB Position: Q3 2016 in Review

Yellowstone Partners increased its iShares Biotechnology ETF (IBB) stake by 2.7% in Q3 2016, buying an estimated $7.13K and bringing the position to 2,835 shares worth $274K. The position accounts for 0.1% of the portfolio, ranked #178.

Yellowstone Partners first reported a position in IBB in Q2 2014 and has held it in 10 quarters since. The position peaked at $375K in Q1 2015. 464 funds tracked by Wall St. Rank hold IBB as of Q3 2016.

Yellowstone Partners held 2,835 shares of iShares Biotechnology ETF worth $274K as of Q3 2016.
Yellowstone Partners bought 75 iShares Biotechnology ETF shares in Q3 2016, an estimated $7.13K.
iShares Biotechnology ETF made up 0.1% of Yellowstone Partners's portfolio in Q3 2016, its #178 holding.
Yellowstone Partners first reported a position in iShares Biotechnology ETF in Q2 2014 and has held it in 10 quarters since.
Yellowstone Partners's iShares Biotechnology ETF position peaked at $375K in Q1 2015.
464 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2016.

Based on Yellowstone Partners's 13F filing for Q3 2016, filed 27 Oct 2016.